Tucker Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60
Closed -$8.27K 813
2025
Q4
$8.27K Buy
+60
New +$7.86K ﹤0.01% 612
2025
Q1
Sell
-2,405
Closed -$234K 717
2024
Q4
$234K Buy
2,405
+2,384
+11,352% +$254K 0.02% 119
2024
Q3
$2.42K Hold
21
﹤0.01% 1122
2024
Q2
$2.24K Buy
+21
New +$2.11K ﹤0.01% 1287
2024
Q1
Sell
-31
Closed -$3.13K 1744
2023
Q4
$3.13K Sell
31
-2
-6% -$193 ﹤0.01% 1025
2023
Q3
$3.36K Hold
33
﹤0.01% 921
2023
Q2
$3.33K Sell
33
-40
-55% -$4K ﹤0.01% 758
2023
Q1
$6.72K Hold
73
﹤0.01% 642
2022
Q4
$6.69K Hold
73
﹤0.01% 401
2022
Q3
$5.92K Buy
73
+42
+135% +$3.48K ﹤0.01% 401
2022
Q2
$2.62K Hold
31
﹤0.01% 423
2022
Q1
$2.72K Buy
+31
New +$2.68K ﹤0.01% 391
2021
Q2
Sell
-419
Closed -$35.8K 362
2021
Q1
$35.8K Buy
419
+201
+92% +$18K 0.02% 94
2020
Q4
$20.6K Buy
+218
New +$19K 0.01% 137

Other funds holding NVS

Tucker Asset Management's NVS Position: Q1 2026 in Review

Tucker Asset Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 60 shares — an estimated $8.27K sold.

Tucker Asset Management first reported a position in NVS in Q4 2020 and held it in 14 quarters. The position peaked at $234K in Q4 2024. 1,601 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Tucker Asset Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 60 Novartis shares in Q1 2026, an estimated $8.27K.
  • Tucker Asset Management first reported a position in Novartis in Q4 2020 and held it in 14 quarters.
  • Tucker Asset Management's Novartis position peaked at $234K in Q4 2024.
  • 1,601 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.